BUSINESS● LOW1h ago · Sep 10, 2026, 10:33 PM
Edwards Lifesciences praises CMS NCD on transcatheter aortic valve replacement
Seeking Alpha Tech · north america
Edwards Lifesciences has expressed approval for the Centers for Medicare & Medicaid Services' National Coverage Determination regarding transcatheter aortic valve replacement. This is a significant development for the company and the medical device sector.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESS29m agoFrequency Electronics signals capacity expansion that could pull forward its $150M+ fiscal 2029 revenue target following $73M equity raiseSeeking Alpha TechBUSINESS29m agoIbex forecasts FY2027 revenue of $700M-$715M as Sierra AI partnership scalesSeeking Alpha TechBUSINESS42m agoTSMC Posts Record Revenue as AI Demand Outruns 20 - Fab Buildouthngn.com · United StatesBUSINESS42m agoMedowie property : Secure $300 , 000 annual return with KFC , dental | Newcastle Heraldnewcastleherald.com.au